Budge James 4

What Happened
James Budge, Chief Financial Officer of Hinge Health, sold a total of 14,763 shares in open-market transactions on February 23, 2026. The three tranches were: 7,566 shares at an average $38.74 ($293,077), 6,297 shares at an average $39.90 ($251,271), and 900 shares at an average $40.43 ($36,389), for aggregate proceeds of roughly $580,737. These were sales (not purchases) and therefore represent dispositions of stock rather than new investment.

Key Details

• Transaction date: February 23, 2026; Form 4 filed February 24, 2026 (timely filing).
• Instrument/Type: Open-market sales (code S).
• Lots and reported averages:
  • 7,566 shares @ $38.74 — total $293,077 (range reported: $38.40–$39.37).
  • 6,297 shares @ $39.90 — total $251,271 (range reported: $39.40–$40.39).
  • 900 shares @ $40.43 — total $36,389 (range reported: $40.40–$40.46).
• Total shares sold: 14,763; total proceeds ≈ $580,737.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted June 12, 2025 (pre-arranged plan). The filing includes weighted-average prices and ranges; the reporting person will provide a per-price breakdown to the SEC or issuer upon request.

Context
Sales executed under a Rule 10b5-1 plan are pre-scheduled dispositions and are generally treated as routine insider liquidity rather than a contemporaneous signal of view on the company. This filing shows dispositions only (no option exercises, awards, or purchases reported).